Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 224

    1.

    Transporter associated protein expression in uveal melanoma.

    Krishnakumar S, Lakshmi SA, Abhyankar D, Biswas J.

    Br J Ophthalmol. 2004 Jul;88(7):925-8.PMID: 15205239 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.

    Krishnakumar S, Abhyankar D, Sundaram AL, Pushparaj V, Shanmugam MP, Biswas J.

    Clin Cancer Res. 2003 Sep 15;9(11):4159-64.PMID: 14519640 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features.

    Krishnakumar S, Abhyankar D, Lakshmi SA, Shanmugam MP, Pushparaj V, Biswas J.

    Exp Eye Res. 2003 Aug;77(2):175-80.PMID: 12873447 [PubMed - indexed for MEDLINE]Related articles

    4.

    HLA expression in choroidal melanomas: correlation with clinicopathological features.

    Krishnakumar S, Abhyankar D, Lakshmi SA, Pushparaj V, Shanmugam MP, Biswas J.

    Curr Eye Res. 2004 Jun;28(6):409-16.PMID: 15512948 [PubMed - indexed for MEDLINE]Related articles

    5.

    Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.

    Tao J, Li Y, Liu YQ, Li L, Liu J, Shen X, Shen GX, Tu YT.

    Br J Dermatol. 2008 Jan;158(1):88-94. Epub 2007 Nov 10.PMID: 17999701 [PubMed - indexed for MEDLINE]Related articles

    6.

    [HLA class I antigen expression correlates with histological cell type in uveal melanoma]

    Dithmar S, Crowder J, Jager MJ, Vigniswaran N, Grossniklaus HE.

    Ophthalmologe. 2002 Aug;99(8):625-8. German. PMID: 12227276 [PubMed - indexed for MEDLINE]Related articles

    7.

    Loss of antigen-processing molecules in primary orbital melanoma.

    Krishnakumar S, Lakshmi S, Abhyankar D, Biswas J.

    Orbit. 2003 Dec;22(4):265-70.PMID: 14685900 [PubMed - indexed for MEDLINE]Related articles

    8.

    Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

    Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ.

    Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1865-72.PMID: 9286277 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Association of HLA class I and class II antigen expression and mortality in uveal melanoma.

    Ericsson C, Seregard S, Bartolazzi A, Levitskaya E, Ferrone S, Kiessling R, Larsson O.

    Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2153-6.PMID: 11527924 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.

    Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B.

    Clin Cancer Res. 2005 Apr 1;11(7):2552-60.PMID: 15814633 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Expression of HLA class I, beta(2)-microglobulin and HLA class II antigens in primary orbital melanoma.

    Krishnakumar S, Lakshmi S, Abhyankar D, Biswas J.

    Orbit. 2003 Dec;22(4):257-63.PMID: 14685899 [PubMed - indexed for MEDLINE]Related articles

    12.

    Expression of classic and nonclassic HLA class I antigens in uveal melanoma.

    Anastassiou G, Rebmann V, Wagner S, Bornfeld N, Grosse-Wilde H.

    Invest Ophthalmol Vis Sci. 2003 May;44(5):2016-9.PMID: 12714638 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.

    Blom DJ, Mooy CM, Luyten GP, Kerkvliet S, Ouwerkerk I, Zwinderman AH, Schrier PI, Jager MJ.

    J Pathol. 1997 Jan;181(1):75-9.PMID: 9072006 [PubMed - indexed for MEDLINE]Related articles

    14.

    HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.

    Vitale M, Pelusi G, Taroni B, Gobbi G, Micheloni C, Rezzani R, Donato F, Wang X, Ferrone S.

    Clin Cancer Res. 2005 Jan 1;11(1):67-72.PMID: 15671529 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease.

    Cresswell AC, Sisley K, Laws D, Parsons MA, Rennie IG, Murray AK.

    Melanoma Res. 2001 Jun;11(3):275-81.PMID: 11468516 [PubMed - indexed for MEDLINE]Related articles

    16.

    Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.

    Anastassiou G, Coupland SE, Stang A, Boeloeni R, Schilling H, Bornfeld N.

    J Pathol. 2001 Aug;194(4):466-72.PMID: 11523055 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cripto-1 expression in uveal melanoma: an immunohistochemical study.

    Mallikarjuna K, Vaijayanthi P, Krishnakumar S.

    Exp Eye Res. 2007 Jun;84(6):1060-6. Epub 2007 Feb 7.PMID: 17412323 [PubMed - indexed for MEDLINE]Related articles

    18.

    Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.

    Hicklin DJ, Kageshita T, Ferrone S.

    Tissue Antigens. 1996 Jul;48(1):38-46.PMID: 8864173 [PubMed - indexed for MEDLINE]Related articles

    19.

    Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.

    Kovalcsik E, John J, Turner M, Birchall L, Sage D, Whittle R, Dalgleish A, Pandha H.

    Melanoma Res. 2004 Dec;14(6):463-71.PMID: 15577316 [PubMed - indexed for MEDLINE]Related articles

    20.

    Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.

    Luyten GP, Mooy CM, Post J, Jensen OA, Luider TM, de Jong PT.

    Cancer. 1996 Nov 1;78(9):1967-71.PMID: 8909318 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data